Abstract
Flaxseeds are not only the richest plant source of α-linolenic acid (ALA, 18:3n-3) and the phytohormone lignans, but also an essential source of high-quality protein and dietary fiber. Whole flaxseed contains 41 % oil by weight, of which 70 % is polyunsaturated; more than half of the total fatty acid is ALA (Fig. 3.1) (Bhatty 1995). ALA is also found in soybeans, rapeseed, walnuts, and dark green leafy vegetables (kale, spinach, broccoli, and Brussels sprouts). Potential health benefits of flaxseeds for cardiovascular disease, neurological disorders, and cancer are related to high ALA contents, vegetable protein, soluble fiber, and flavonoids and related compounds, which may not only possess cholesterol-lowering, hyperlipidemic, and antioxidant properties, but may also produce sex hormone agonistic and antagonistic activities (de Lorgeril et al. 1994; Jenkins et al. 1999). Flaxseed lignans also promote the reduction of serum total cholesterol and low-density lipoprotein cholesterol and elevates serum high-density lipoprotein cholesterol. ALA in flaxseed oil does not have antioxidant activity except it suppresses oxygen radical production by white blood cells. In cardiovascular system, flaxseeds and flaxseed oil have variable effects on inflammatory mediators/markers (interleukin, IL-1β, IL-2, IL-4, IL-6, IL-10, tumor necrosis factor-α (TNF-α), interferon-γ, C-reactive protein, and serum amyloid protein). Although doses of ALA less than 14 g/d do not affect inflammatory mediators/markers, 14 g/d or greater reduce inflammatory mediators/markers. ALA in flaxseed oil decreases soluble vascular cell adhesion molecule-1 but has no effect on soluble intracellular adhesion molecule-1, soluble E-selectin, and monocyte colony-stimulating factor. ALA in flaxseeds has a very small hypotensive effect, but it does not lower blood pressure. However, secoisolariciresinol diglucoside (SDG), a component of flaxseed oil, is a very potent hypotensive agent. Flaxseed oil also decreases platelet aggregation and increases platelet activating inhibitor-1 and bleeding time. A meta-analysis of observational studies indicates that increased consumption of ALA may reduce coronary heart disease mortality by 21 % (Brouwer et al. 2004). In the Lyon Diet Heart Study, a randomized controlled trial in coronary patients, consumption of a Mediterranean-type diet that included an additional daily intake of roughly 1 g of ALA significantly reduces the risk of cardiac death and nonfatal myocardial infarction by more than 60 % (Lorgeril et al. 1994). This study, however, was not specifically designed to assess the effect of ALA supplementation, and many dietary factors were included, which differed between the experimental and control group. Collective evidence suggests that ALA status has been inversely associated with cardiovascular disease events, although data are less consistent than for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The biologic mechanisms of ALA action may include platelet function, inflammation, endothelial cell function, arterial compliance, and arrhythmia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abumrad NA, El Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA (1993) Cloning of rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that induced during pre-adipocyte differentiation. J Biol Chem 268:17665–17668
Ahmad A, Moriguchi T, Salem N Jr (2002) Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatr Neurol 26:210–218
Aid S, Vancassel S, Linard A, Lavialle M, Guesnet P (2005) Dietary docosahexaenoic acid [22:6(n-3)] as a phospholipid or a triglyceride enhances the potassium chloride-evoked release of acetylcholine in rat hippocampus. J Nutr 135:1008–1013
Ander BP, Weber AR, Rampersad PP, Gilchrist JS, Pierce GN, Lukas A (2004) Dietary flaxseed protects against ventricular fibrillation induced by ischemia-reperfusion in normal and hypercholesterolemic Rabbits. J Nutr 134:3250–3256
Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201:713–722
Arita M, Oh SF, Chonan T, Hong S, Elangovan S, Sun YP, Uddin J, Petasis NA, Serhan CN (2006) Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J Biol Chem 281:22847–22854
Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 178:3912–3917
Arterburn LM, Hall EB, Oken H (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83:1467S–1476S
Astarita G, Jung KM, Berchtold NC, Nguyen VQ, Gillen DL, Head E, Cotman CW, Piomelli D (2010) Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer’s disease. PLoS One 5:e12538
Balk EM, Horsley TA, Newberry SJ, Lichtenstein AH, Yetley EA, Schachter HM, Moher D, MacLean CH, Lau J (2007) A collaborative effort to apply the evidence-based review process to the field of nutrition: challenges, benefits, and lessons learned. Am J Clin Nutr 85:1448–1456
Barden AE, Croft KD, Durand T, Guy A, Mueller MJ, Mori TA (2009) Flaxseed oil supplementation increases plasma F1-phytoprostanes in healthy men. J Nutr 139:1890–1895
Bays HE (2007) Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 99:35C–43C
Bazan NG (2009) Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer’s disease. J Lipid Res 50(Suppl):S400–S405
Bhatty RS (1995) Nutrient composition of whole flaxseed and flaxseed meal. In: Cunnane SC, Thompson LU (eds) Flaxseed in human nutrition. AOCS Press, Champaign, IL, pp 22–42
Birch EE, Hoffman DR, Uauy R, Birch DG, Prestidge C (1998) Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res 44:201–209
Blondeau N, Pétrault O, Manta S, Giordanengo V, Gounon P, Bordet R, Lazdunski M, Heurteaux C (2007) Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res 101:176–184
Blondeau N, Nguemeni C, Debruyne DN, Piens M, Wu X, Pan H, Hu X, Gandin C, Lipsky RH, Plumier JC, Marini AM, Heurteaux C (2009) Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke. Neuropsychopharmacology 34:2548–2559
Bowen RA, Clandinin MT (2005) Maternal dietary 22:6n-3 is more effective than 18:3n-3 in increasing the 22:6n-3 content in phospholipids of glial cells from neonatal rat brain. Br J Nutr 93:601–611
Brand A, Crawford MA, Yavin E (2010) Retailoring docosahexaenoic acid-containing phospholipid species during impaired neurogenesis following omega-3 alpha-linolenic acid deprivation. J Neurochem 114:1393–1404
Brouwer IA, Katan MB, Zock PL (2004) Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 134:919–922
Burdge GC, Wootton SA (2002) Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88:411–420
Burdge GC, Jones AE, Wootton SA (2002) Eicosapentaenoic and docosapentaenoic acids are the principal products of a-linolenic acid metabolism in young men. Br J Nutr 88:355–363
Calderon F, Kim HY (2004) Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem 90:979–988
Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N Jr, Ashe KH, Frautschy SA, Cole GM (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model. Neuron 43:633–645
Cansev M, Marzloff G, Sakamoto T, Ulus IH, Wurtman RJ (2009) Giving uridine and/or docosahexaenoic acid orally to rat dams during gestation and nursing increases synaptic elements in brains of weanling pups. Dev Neurosci 31:181–192
Carey MC, Hernell O (1992) Digestion and absorption of fat. Semin Gastrointest Dis 3:189–208
Catalan J, Moriguchi T, Slotnick B, Murthy M, Greiner RS, Salem N Jr (2002) Cognitive deficits in docosahexaenoic aciddeficient rats. Behav Neurosci 116:1022–1031
Cheng X, Liao YH, Ge H, Li B, Zhang J, Yuan J, Wang M, Liu Y, Guo ZQ (2005) Th1/Th2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol 25:246–253
Cupp D, Kampf JA, Kleinfield AM (2004) Linolenic acid transport in hamster intestinal cells is carrier-mediated. Biochemistry 43:4473–4481
Dangi B, Obeng M, Nauroth JM, Chung G, Bailey-Hall E, Hallenbeck T, Arterburn LM (2010) Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6). Biochem Pharmacol 79:251–260
de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343:1454–1459
De Stéfani E, Deneo-Pellegrini H, Boffetta P, Ronco A, Mendilaharsu M (2000) Alpha-linolenic acid and risk of prostate cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev 9:335–338
de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T (2000) Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290:2140–2144
Delion S, Chalon S, Guillotaeu D, Besnard J-C, Durand G (1996) alpha-Linolenic acid deficiency alters age-related changes of dopaminergic and serotonergic neurotransmission in the rat frontal cortex. J Neurochem 66:1582–1591
Eckert GP, Franke C, Nöldner M, Rau O, Wurglics M, Schubert-Zsilavecz M, Müller WE (2010) Plant derived omega-3-fatty acids protect mitochondrial function in the brain. Pharmacol Res 61:234–241
Farooqui AA (2009) Beneficial effects of fish oil on human brain. Springer, New York
Farooqui AA (2010) Neurochemical Aspects of Neurological Disorders. Springer, New York
Farooqui AA (2011) Lipid mediators and their metabolism in the brain. Springer, New York
Farooqui AA, Ong WY, Horrocks LA (2003) Plasmalogens, docosahexaenoic acid and neurological disorders. Adv Exp Med Biol 544:335–354
Fratiglioni L, Qiu C (2009) Prevention of common neurodegenerative disorders in the elderly. Exp Gerontol 44:46–50
Gao L, Wang J, Sekhar KR, Yin H, Yared NF, Schneider SN, Sasi S, Dalton TP, Anderson ME, Chan JY, Morrow JD, Freeman ML (2007) Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem 282:2529–2537
Gawrisch K, Eldho NV, Holte LL (2003) The structure of DHA in phospholipid membranes. Lipids 38:445–452
Gerster H (1998) Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Nutr Res 68:159–173
Goré J, Hoinard C (1993) Linolenic acid transport in hamster intestinal cells is carrier-mediated. J Nutr 123:66–73
Green P, Glozman S, Kamensky B, Yavin E (1999) Developmental changes in rat brain membrane lipids and fatty acids – preferential accumulation of docosahexaenoic acid. J Lipid Res 40:960–966
Guizy M, David M, Arias C, Zhang L, Cofan M, Ruiz-Gutierrez V, Ros E, Lillo MP, Martens JR, Valenzuela C (2008) Modulation of the atrial specific Kv1.5 channel by the n_3 polyunsaturated fatty acid, alpha-linolenic acid. J Mol Cell Cardiol 44:323–335
Gutermuth J, Bewersdorff M, Traidl-Hoffman C, Ring J, Mueller MJ, Behrendt H (2007) Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo. J Allergy Clin Immunol 120:293–299
Hamilton JA, Brunaldi K (2007) A model for fatty acid transport into the brain. J Mol Neurosci 33:12–17
Han X, Holtzman DM, McKeel DW Jr, Kelley J, Morris JC (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer’s disease: potential role in disease pathogenesis. J Neurochem 82:809–818
He C, Qu X, Cui L, Wang J, Kang JX (2009) Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc Natl Acad Sci USA 106:11370–11375
Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, Lang-Lazdunski L, Widmann C, Zanzouri M, Romey G, Lazdunski M (2004) TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J 23:2684–2695
Hibbeln JR (1998) Fish consumption and major depression. Lancet 351:1213
Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem 278:14677–14687
Horrocks LA, Farooqui AA (2004) Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot Essent Fatty Acids 70:361–372
Igarashi M, DeMar JC Jr, Ma K, Chang L, Bell JM, Rapoport SI (2007) Upregulated liver conversion of alpha-linolenic acid to docosahexaenoic acid in rats on a 15 week n-3 PUFA-deficient diet. J Lipid Res 48:152–164
Innis SM (1991) Essential fatty acids in growth and development. Prog Lipid Res 30:39–103
Jenkins DJ, Kendall CW, Vidgen E, Agarwal S, Rao AV, Rosenberg RS, Diamandis EP, Novokmet R, Mehling CC, Perera T, Griffin LC, Cunnane SC (1999) Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr 69:395–402
Karg K, Dirsch V, Vollmar AM, Crackowski JL, Laporte F, Mueller MJ (2007) Biologically active oxidized lipids (phytoprostanes) in the plant diet and parental lipid nutrition. Free Radic Res 41:25–37
Kempermann G, Neumann H (2003) Neuroscience. Microglia: the enemy within? Science 302:1689–1690
Kim HY, Akbar M, Lau A, Edsall L (2000) Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem 275:35215–35223
Kim M, Nam JH, Oh DH, Park Y (2010) Erythrocyte α-linolenic acid is associated with the risk for mild dementia in Korean elderly. Nutr Res 30:756–761
King VR, Huang WL, Dyall SC, Curran OE, Priestley JV, Michael-Titus AT (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 26:4672–4680
Knapp HR (1997) Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 65(5 Suppl):1687S–1698S
Kodas E, Vancassel S, Lejeune B, Guilloteau D, Chalon S (2002) Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage. J Lipid Res 43:1209–1219
Kuperstein F, Yakubov E, Dinerman P, Gil S, Eylam R, Salem N Jr, Yavin E (2005) Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n-3 fatty acid dietary deficiency. J Neurochem 95:1550–1562
Kuperstein F, Eilam R, Yavin E (2008) Alterations in dopaminergic key regulatory proteins following perinatal n-3 fatty acid dietary deficiency. J Neurochem 106:662–671
Kurvinen JP, Kuksis A, Sinclair AJ, Abedin L, Kallio H (2000) The effect of low alpha-linolenic acid diet on glycerophospholipid molecular species in guinea pig brain. Lipids 35:1001–1009
Lafourcade M, Larrieu T, Mato S, Duffaud A, Sepers M, Matias I, De Smedt-Peyrusse V, Labrousse VF, Bretillon L, Matute C, Rodríguez-Puertas R, Layé S, Manzoni OJ (2011) Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci 14:345–350
Lemaire V, Koehl M, Le Moal M, Abrous DN (2000) Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci USA 97:11032–11037
Li Z, Kaplan ML, Hatchey DL (2000) Hepatic microsomal and peroxisomal docosahexaenoate biosynthesis during piglet development. Lipids 35:1325–1333
Lim GP, Calon F, Morihara T (2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25:3032–3040
Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343:1454–1459
Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115:2774–2783
Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278:43807–43817
Marcheselli VL, Mukherjee PK, Arita M, Hong S, Antony R, Sheets K, Winkler JW, Petasis NA, Serhan CN, Bazan NG (2010) Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot Essent Fatty Acids 82:27–34
Mariani V, Gilles S, Jakob T, Thiel M, Mueller MJ, Ring J, Behrendt H, Traidl-Hoffmann C (2007) Immunomodulatory mediators from pollen enhance the migratory capacity of dendritic cells and license them for Th2 attraction. J Immunol 178:7623–7631
Matsumura K (2007) Effects of eicosapentaenoic acid on visceral fat and heart rate variability: assessment by power spectral analysis. J Cardiol 50:243–251
McLennan PL, Dallimore JA (1995) Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. J Nutr 125:1003–1009
Michael-Titus AT (2007) Omega-3 fatty acids and neurological injury. Prostaglandins Leukot Essent Fatty Acids 77:295–300
Morgane PJ, Austin-Lafrance R, Bronzino J, Tonkiss J, Diaz-Cintra S, Cintra L, Kemper T, Galler JR (1993) Prenatal malnutrition and development of the brain. Neurosci Biobehav Rev 17:91–128
Mori TA, Beilin LJ (2004) Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 6:461–467
Moriguchi T, Greiner RS, Salem N Jr (2000) Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 75:2563–2573
Nestel PJ, Pomeroy SE, Sasahara T, Yamashita T, Liang YL, Dart AM, Jennings GL, Abbey M, Cameron JD (1997) Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol 1997(17):1163–1170
Neuringer M (2000) Infant vision and retinal function in studies of dietary long-chain polyunsaturated fatty acids: methods, results, and implications. Am J Clin Nutr 71:256S–267S
Nguemeni C, Delplanque B, Rovère C, Simon-Rousseau N, Gandin C, Agnani G, Nahon JL, Heurteaux C, Blondeau N (2010) Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res 61:226–233
Pang D, lman-Farinelli MA, Wong T, Barnes R, Kingham KM (1998) Replacement of linoleic acid with alpha-linolenic acid does not alter blood lipids in normolipidaemic men. Br J Nutr 80:163–167
Peet M (2003) Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids 69:477–485
Peet M, Strokes C (2005) Omega-3 fatty acids in the treatment of psychiatric disorders. Drug 65:1051–1059
Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43:315–319
Phillis JW, Horrocks LA, Farooqui AA (2006) Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev 52:201–243
Portolesi R, Powell BC, Gibson RA (2007) Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. J Lipid Res 48:1592–1598
Poumes-Ballihaut C, Langelier B, Houlier F, Alessandri JM, Durand G, Latge C (2001) Comparative bioavailability of dietary alpha-linolenic and docosahexaenoic acids in the growing rat. Lipids 36:793–800
Racagni G, Popoli M (2008) Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci 10:385–400
Radominska-Pandya A, Chen G (2002) Photoaffinity labeling of human retinoid X receptor beta (RXRbeta) with 9-cis-retinoic acid: identification of phytanic acid, docosahexaenoic acid, and lithocholic acid as ligands for RXRbeta. Biochemistry 41:4883–4890
Rajamoorthi K, Petrache HI, McIntosh TJ, Brown MF (2005) Packing and viscoelasticity of polyunsaturated omega-3 and omega-6 lipid bilayers as seen by [2]H NMR and X-ray diffraction. J Am Chem Soc 127:1576–1588
Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A (2003) Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 167:237–242
Rosenberger TA, Oki J, Purdon AD, Rapoport SI, Murphy EJ (2002) Rapid synthesis and turnover of brain microsomal ether phospholipids in the adult rat. J Lipid Res 43:59–68
Salem N Jr, Litman B, Kim HY, Gawrisch K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36:945–959
Serhan CN, Chiang N (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153(Suppl 1):S200–S215
Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349–361
Simopoulos AP (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233:674–688
Sinclair AJ, Attar-Bashi NM, Li D (2002) What is the role of alpha-linolenic acid for mammals? Lipids 37:1113–1123
Song C, Zhaq S (2007) Omega-3 fatty acid eicosapentaenoic acid.A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations. Expert Opin Investig Drugs 16:1627–1638
Sprecher H (2000) Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 1486:219–231
Stremmel W (1988) Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein. J Clin Invest 8(2):2001–2010
Su HM, Bernardo L, Mirmiran M, Ma XH, Corso TN, Nathanielsz PW, Brenna JT (1999a) Bioequivalence of dietary alpha-linolenic and docosahexaenoic acids as sources of docosahexaenoate accretion in brain and associated organs of neonatal baboons. Pediatr Res 45:87–93
Su HM, Bernardo L, Mirmiran M, Ma XH, Nathanielsz PW, Brenna JT (1999b) Dietary 18:3n-3 and 22:6n-3 as sources of 22:6n-3 accretion in neonatal baboon brain and associated organs. Lipids 34(Suppl):S347–S350
Sutton RB, Fasshauer D, Jahn R, Brunger AT (1998) Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 395:347–353
Talahalli RR, Vallikannan B, Sambaiah K, Lokesh BR (2010) Lower efficacy in the utilization of dietary ALA as compared to preformed EPA + DHA on long chain n-3 PUFA levels in rats. Lipids 45:799–808
Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572–580
Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, Calder PC (2001) Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36:1183–1193
Urano S, Sato Y, Otonari T et al (1998) Aging and oxidative stress in neurodegeneration. Biofactors 7:103–112
Utsunomiya A, Owada Y, Yoshimoto T, Kondo H (1997) Localization of mRNA for fatty acid transport protein in developing and mature brain of rats. Brain Res Mol Brain Res 46:217–222
Venna VR, Deplanque D, Allet C, Belarbi K, Hamdane M, Bordet R (2009) PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 34:199–211
Williams CM, Burdge G (2006) Long-chain n-3 PUFA: plant v. marine sources. Proc Nutr Soc 65:42–50
Zhang DD (2006) Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38:769–789
Zimmer L, Delion-Vancassel S, Durand G, Guilloteau D, Bodard S, Besnard JC, Chalon S (2000) Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41:32–40
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Farooqui, A.A. (2013). Beneficial Effects of Flaxseed Oil (n-3 Fatty Acids) on Neurological Disorders. In: Phytochemicals, Signal Transduction, and Neurological Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3804-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3804-5_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3803-8
Online ISBN: 978-1-4614-3804-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)